Skip to main content

Corporate Iatrogenesis

Meaning

Corporate Iatrogenesis refers to the systemic harm, disease, or adverse health outcomes inflicted upon populations not by individual clinical error, but as a direct or indirect consequence of policies, products, or marketing practices driven by corporate interests, particularly within the pharmaceutical and wellness industries. This concept highlights how profit motives can inadvertently or deliberately lead to the over-medicalization of normal physiological states, the promotion of suboptimal or unnecessary interventions, or the downplaying of genuine risks. Recognizing Corporate Iatrogenesis is essential for discerning trustworthy information in the hormonal health space and protecting patient autonomy.